Gait Analysis Laboratory, Department of Orthopedic Surgery, Hvidovre University Hospital
Hvidovre, DK-2650, Denmark
NCT Number: NCT00552721
It is the primary purpose of this pilot study to investigate if physical therapy with strength training is better at improving muscle and gait function after anti-spastic treatment with Botulinum toxin compared to physical therapy without strength training in children with cerebral palsy. The investigators hypothesize that it is.
Looking for future studies?
Notify Me7 year–18 year
All sexes
Interventional
Not applicable
Hvidovre, DK-2650, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
12 weeks of physical therapy after Botulinum-toxin treatment (two 45-min sessions/week) with an emphasis on strength training.
12 weeks of physical therapy after Botulinum-toxin treatment (two 45-min sessions/week) without strength training.
Time frame: 12 weeks
Time frame: 12 weeks
Time frame: 12 weeks
Time frame: 12 weeks
Hvidovre University Hospital
Other
Physical Therapy With Versus Without Strength Training After Botulinum-toxin Treatment in Children With Cerebral Palsy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06117020
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
San Antonio, Texas, United States
View Trial DetailsNCT07613515
Brain Damage, Chronic, Brain Diseases
Jeddah, Saudi Arabia
View Trial DetailsNCT06536751
Brain Damage, Chronic, Brain Diseases
São Paulo, Brazil
View Trial DetailsNCT07346430
Anxiety, Anxiety Disorders
Cairo, Egypt
View Trial Details